Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Jenrry Mejia

Red Sox To Sign Jenrry Mejia

By | at

The Red Sox have inked a minor-league deal with former MLB reliever Jenrry Mejia, according to Jon Heyman of Fancred (Twitter link). He’ll head to Spring Training (though not MLB camp, Heyman notes) in search of a comeback from a lengthy absence — one that was occasioned by his own incredibly poor decisionmaking. The contract would pay him $625K in the Majors, USA Today’s Bob Nightengale tweets.

Mejia, of course, was once a key late-inning reliever for the Mets. That all changed when he was mind-numbingly popped for PED-related violations on three occasions, leading to a lifetime ban. While commissioner Rob Manfred ultimately lifted that prohibition, Mejia is now long removed from his big league career. The 29-year-old last appeared on the MLB mound in the middle of the 2015 season.

Before he cost himself a major chunk of his prime, Mejia had shown some interesting abilities on the bump. After failing to exhibit quite enough as a starter to earn a full chance in the New York rotation, he slid comfortably into the team’s bullpen in 2014. Over 56 1/3 relief innings that year, he worked to a 2.72 ERA with a 60:21 K/BB ratio. Mejia ultimately took the closer’s job, locking down 28 games.

Just what’s left in the tank isn’t known, but the Red Sox will take a shot on the talent of the enigmatic right-hander. That the defending World Series champs have now added Mejia while otherwise waiting out the relief market is sure to draw some curious glances, from both fans who’d like to see more additions and from those on the players side that believe teams need to be spending more money. Obviously, this sort of move will not itself preclude the Boston powerhouse from making further acquisitions, but the timing certainly creates some interesting juxtapositions.

MLB Reinstates Jenrry Mejia For 2019 Season

By | at

Major League Baseball announced today that Mets reliever Jenrry Mejia will be reinstated for the 2019 season. He had previously been banned following a third positive PED test.

Mejia, who is now 28 years of age, last pitched in the majors in 2015. He has been on the restricted list since that time.

While the ban will not be lifted until next season, Mejia will be able to begin working out at Mets facilities after the All-Star break, per the announcement. He’ll also be eligible to take a rehab assignment this August and participate in Spring Training in 2019.

It comes as something of a surprise to see Mejia given a path back to playing, though of course he was never released by the organization precisely because it remained a possibility. Indeed, the Joint Drug Program allows banned players to seek reinstatement after two years away.

Mejia, though, seemingly burned some bridges by launching claims of a conspiracy that were vigorously contested by the league. In his comments today, released through the MLBPA, Mejia acknowledged “the false allegations [he] made about Major League Baseball’s investigation into my testing history.” He also offered apologies all around and specifically thanked Commissioner Rob Manfred for allowing him back into the game.

Ultimately, this represents great news for Mejia but also, potentially, a nice turn for the Mets. Though the righty has certainly caused some headaches in Queens over the years, he’s still youthful and has mostly been a quality MLB reliever — even serving as the organization’s closer at times in 2014.

That said, the upside for the New York organization is somewhat limited. The club said in a statement only that it will assess its options after seeing Mejia on the field. Though Ken Davidoff of the New York Post reported in 2016 that Mejia would continue earning service time while technically banned, Tim Britton of The Athletic tweets today that Mejia will be deemed to have four years and 140 days entering the winter. If the Mets choose to tender him a contract, they’ll presumably revert to his most recent salary ($1.729MM) and would possess control rights through 2020.

NL Notes: Brewers, Padres, Mets

By | at

A quick look around the National League…

  • The Brewers are arguably in position to spend big on a free agent starting pitcher this offseason, but it’s unlikely to happen “unless prices come down,” Tom Haudricourt of the Milwaukee Journal Sentinel writes. General manager David Stearns claims he’s “comfortable” with the team’s current rotation options – including the newly signed duo of Jhoulys Chacin and Yovani Gallardo. At the same time, he’s still working to improve the Brewers’ pitching and other areas of their roster. “I wouldn’t say we have anything that is imminent,” he told Haudricourt. “But that can always change with one phone call. We are involved on a number of fronts, some of them farther along than others. We’ll see where that takes us.”
  • Outfield prospect Edward Olivares is someone San Diego had “been on for some time” before acquiring him in Saturday’s Yangervis Solarte trade with Toronto, Padres general manager A.J. Preller said (via Dennis Lin of the San Diego Union-Tribune). Preller went on to reveal that the Padres may not be done trading infielders, even after shipping out Solarte. “We’re still having discussions on the different infielders, and we’ll see how things play out,” stated Preller, who admitted after acquiring third baseman Chase Headley last month that he could flip him. Other teams had also called about Cory Spangenberg and Carlos Asuaje at that point.
  • The Mets and reliever Jenrry Mejia avoided arbitration this week, settling on a $1.729MM salary, according to Jon Heyman of FanRag (Twitter link). However, Mejia isn’t in position to collect that money, as Heyman notes. Major League Baseball issued Mejia a lifetime ban in February 2016 after his third positive test for performance-enhancing drugs.

NL East Notes: Freeman, Strasburg, Harper, Turner, Mejia

By | at

Braves first baseman Freddie Freeman left today’s spring action with a right wrist issue, as David O’Brien of the Atlanta Journal-Constitution reports. Such a potentially minor occurrence might not warrant mention for most players, but Freeman missed significant time last year owing to issues in the same area, and he was proceeding cautiously as he ramps up for the 2016 season. (Indeed, as O’Brien has previously written, Freeman has long dealt with difficulties in his right wrist and hand.) For now, it’s only a situation to monitor, but there’s obviously added concern in his case.

Here’s more on Freeman and some other interesting players in the NL East:

  • Of course, Freeman was the topic of plenty of trade speculation this winter as the Braves continued to tweak their player assets — at least until GM John Coppolella made as clear as possible that Freeman wouldn’t be going anywhere. ESPN.com’s Jayson Stark explores the big lefty’s interesting offseason, reporting that Atlanta may have been closer to moving Freeman at one point than the organization has been willing to acknowledge. Coppolella denies that anything ever seriously progressed, while acknowledging that there was outside interest (which, of course, is no surprise). Freeman himself said he heard a lot of the chatter, but was eventually put to ease by the front office. And Coppolella explains that the first bagger is the organization’s “rock.” You’ll want to read the whole piece for the full story, as it is full of interesting content.
  • Nationals GM Mike Rizzo had some interesting comments today in an interview with MLB Network Radio on Sirius XM (audio link). He said that righty Stephen Strasburg “could be a long-term fit” in DC and suggested that the organization would seek to explore a new deal with the pending free agent. While “health is obviously a big factor with him,” said Rizzo, it seems clear that the Nats at least have interest in seeing what an extension (or, potentially, a free agent deal) would look like. The club GM and president also talked about star Bryce Harper’s long-term status, saying that the “money part of it … is going to be extreme and complicated” while noting that he feels the Nationals have done a good job of selling Harper on the organization as a fit down the line.
  • Rizzo also talked more Nationals matters on the podcast of ESPN.com’s Buster Olney. In addition to providing some more thoughts about Strasburg and Harper, more from an on-field than a contractual perspective, Rizzo spoke at length about top shortstop prospect Trea Turner. The Nats’ head baseball decisionmaker wouldn’t commit to an Opening Day roster job for the youngster, but also didn’t rule it out, and emphasized that Turner is “not far away from the big leagues” while crediting him not only with 80-grade speed, but also outstanding maturity. As for the deal that brought him to DC, Rizzo tipped his cap to the scouts who helped to identify Turner and Joe Ross as targets within the Padres organization. He explained further: “[W]hen they showed interest in Steven Souza … we made it clear that, you know, we had to have these two players in the trade or we wouldn’t be interested in moving Souza.” The Nats were able to “get[] involved in a three-team trade later in the process” — the Rays, of course, being the organization that ultimately ended up with Souza — to land a return that has looked quite promising ever since the deal was struck.
  • Mets reliever Jenrry Mejia spoke again with the media today, emphasizing — as he said recently — that he was not using any banned substances when he was tagged with his second and third positive tests, as Laura Albanese of Newsday reports (Twitter links). While he acknowledged his initial suspension was valid, he “framed it as an accident,” by Albanese’s characterization. Adam Rubin of ESPNNewYork.com notes on Twitter that it appears Mejia’s lifetime ban was never formally appealed, so there may be some possibility that he could still have a chance at contesting the decision. As Nathaniel Vinton of the New York Daily News reports, it appears Mejia will attempt to do just that, though it should be noted there could well be procedural hurdles. For its part, the league issued a strong statement rejecting Mejia’s claims of a conspiracy against him, calling the righty a “repeated user of banned performance-enhancing substances” who is doing nothing more than “hiring aggressive lawyers and making wild, unsupported allegations about the conduct of others in an effort to clear their names.” Newsday’s David Lennon was among those to tweet the full statement.

NL East Notes: Mets, deGrom, Mejia, De Aza, Nola, Capps

By | at

Longtime Mets media relations executive Shannon Forde passed away this evening after an extended battle with breast cancer. She was only 44 years of age, and leaves behind a husband and two young children. Her loss has sparked a remarkable outpouring of grief, and it is evident that she had a huge impact on many people who worked for or around the team. We recommend this piece from Joel Sherman of the New York Post as we join so many others in expressing our sympathies to her family and friends.

Here are some notes from New York and the NL East:

  • Mets GM Sandy Alderson said today that there are no current extension talks with the team’s slate of young starters, as MLB.com’s Anthony DiComo reports. Emphasizing that he doesn’t see much “urgency” given the length of control over most of the club’s key pitchers, Alderson said that it’s also rather early in camp for such discussions to be held. “There hasn’t been any discussion with any of our starting pitchers,” he said, “not because we’re unwilling or because there isn’t any interest on the part of the players necessarily — just we are where we are in the spring-training schedule. It’s a little early. Agents don’t typically come in until later. I don’t think you can draw anything from that.”
  • Meanwhile, the Mets renewed the contract of surprise ace Jacob deGrom at a rate of $607K, which is well above the minimum salary but also hardly reflects his outstanding contributions over the last two seasons. While deGrom declined to agree to that deal — a symbolic formality — it doesn’t appear that there’s any cause for hard feelings going forward, as DiComo further reports.  “We haven’t talked about anything yet, and I don’t think this will affect that in any way,” said deGrom. “I think we’re still open to discussions for long-term things, but nothing’s in the works now.” For what it’s worth, as I’ve suggested before, I see deGrom as the likeliest of the New York hurlers to sign on to a long-term contract given his high rate of play, relatively advanced age, and approaching arbitration eligibility.
  • Another Mets pitcher, banned reliever Jenrry Mejia, claims that he was only guilty of one of his three PED-related suspensions, as he tells Ben Berkon of the New York Times. He also accused the league of participating in some kind of “conspiracy” against him and suggested that the union had failed to adequately defend him. An MLB spokesman denied that any league official had ever even met with Mejia relating to his trio of failed drug tests. As Berkon notes, his comments don’t seem likely to help him if he chooses to seek reinstatement, though he has some time to think about how to approach that matter.
  • The Mets haven’t received any interest in outfielder Alejandro De Aza and aren’t shopping him, Mike Puma of the New York Post recently tweeted. Though the veteran outfielder’s utility was greatly lessened when the club made a late strike for Yoenis Cespedes, it seems that it will take a change in circumstances for him to be moved to another organization.
  • Aaron Nola impressed in his first 77 2/3 innings last year for the Phillies, and he tells MLBTR’s Zach Links (via Twitter) that he’s not interested in easing his way into things this year. “I want to go 200+ innings. I want to throw as many innings as I can,” Nola said recently. Actually, that seems like rather an attainable goal, as he ran up 109 1/3 innings in the minors last year.
  • The Marlins are waiting to see what Dr. James Andrews recommends on Monday with regard to key reliever Carter Capps, Barry Jackson of the Miami Herald reports. Miami won’t seek to strike a deal for another pen arm before that time, per the report, but it seems that an addition may well be contemplated if an extended absence results. At this point, even in the best of circumstances it seems likely that Capps will be required to spend some time resting and rehabbing.

Mets Notes: Mejia, Bullpen, Edgin, De Aza

By | at

Jenrry Mejia’s stunning lifetime suspension for failing a third PED test is still fresh on the minds of most Mets fans, and Ken Davidoff of the New York Post runs down some of the intricacies of the Joint Drug Agreement’s ban. As Davidoff notes, Mejia remains property of the Mets and will gain Major League service time even though he is suspended. As such, the Mets will have to officially non-tender Mejia next offseason. Mejia is banned for at least two years, but he can apply for reinstatement after one year. Reinstatement seems unlikely, and as Davidoff notes, both the Korea Baseball Organization and Nippon Professional Baseball honor MLB disciplinary measures, so Mejia isn’t likely to latch on overseas, either. He could play independent ball if the Mets grant him permission, and as Davidoff notes, the Mets may feel no reason to prevent him from doing so.

Here’s the latest on the Mets…

  • Jon Heyman tweets that the Mets still “have [their] eyes open” for bullpen help in the wake of Mejia’s suspension. Presently, Addison Reed, Hansel Robles and Erik Goeddel are poised to serve as right-handed setup options for closer Jeurys Familia, while Antonio Bastardo, Jerry Blevins and Sean Gilmartin are all in the mix as options from the left side.
  • Lefty Josh Edgin, who is recovering from Tommy John surgery, is aiming for a May 1 return, tweets MLB.com’s Anthony DiComo. While that return will, of course, be largely dependent on how his rehab progresses this spring and throughout the month of April, Edgin would give the Mets a quality fourth option as a left-hander. Edgin logged a 1.32 ERA in 27 1/3 innings for the Mets in 2014 and looked poised to be a key ’pen member going forward prior to his injury.
  • The re-signing of Yoenis Cespedes essentially made Alejandro De Aza a superfluous fifth outfielder for the Mets, but the team has no plans to attempt to trade him right now, Ken Rosenthal of FOX Sports reports. Clearly, a trade of De Aza would represent a rare occurrence, as a player that signs as a free agent must give his consent to being traded before June 15. However, De Aza would “almost certainly” consent to a deal now that he’s in line for a dramatically diminished role to the one he thought he was signing up for when he took the Mets’ one-year, $5.75MM offer earlier this winter. The Mets want to make sure that each of Michael Conforto, Curtis Granderson and Cespedes make it through Spring Training without injury before dealing De Aza, though, Rosenthal notes. Additionally, he points out that the presence of David Murphy, Will Venable and Matt Joyce on the free-agent market also makes a trade unlikely, as teams have similar alternatives on the open market. I’d further add that injuries are likely to pop up around the rest of the league and could leave a team that doesn’t stand out as a current fit as a suitor down the line.

Jenrry Mejia Gets Lifetime Ban After Third Positive PED Test

By | at

Mets reliever Jenrry Mejia has been banned permanently from the majors after his third positive PED test, according to a league announcement. Remarkably, Mejia tested positive for the banned substance boldenone after earning two suspensions just last year.

Sep 15, 2014; New York, NY, USA; New York Mets relief pitcher Jenrry Mejia (58) reacts walking to the dugout against the Miami Marlins during the eighth inning at Citi Field. Mandatory Credit: Adam Hunger-USA TODAY Sports

It’s a truly stunning result, made all the more surprising given that Mejia was on track to resume his career with New York. Indeed, he recently agreed to a $2.47MM salary to avoid arbitration. While he was already to sacrifice a good portion of that money to finish serving his second suspension — which was of the 162-game variety — he’ll lose the remainder after today’s news.

Mejia becomes the first player to receive a permanent ban under MLB’s “three strikes and you’re out” PED policy. There is a provision that will allow the 26-year-old righty to seek reinstatement, Adam Rubin of ESPNNewYork.com notes on Twitter. But even if successful, he’d have to wait one year to ask and serve a minimum two-year ban.

In a statement, the Mets said that the club is “deeply disappointed” in Mejia. He had seemed destined to return to a prominent place in the club’s pen after finishing out his second ban. While New York seemed primed to cut ties at one point, the upside in Mejia’s cheap contract and rested, youthful arm certainly justified the risk. But Mejia somehow proved unable to avoid PED usage even while subject to stepped-up testing as a prior offender.

After failing to hold down a rotation job in 2014, Mejia had shown real promise in a relief role. He ended that campaign as the team’s closer, posting 28 saves and working to a 2.72 ERA over 56 1/3 innings out of the pen. While he has since been supplanted in the ninth by Jeurys Familia, Mejia certainly seemed to have a plausible chance of winning back a set-up role later in the 2015 season.

Photo courtesy of USA Today Sports Images.

Mets Avoid Arbitration With Lucas Duda, Jenrry Mejia

By | at

The Mets have reached agreements to avoid arbitration with first baseman Lucas Duda and reliever Jenrry Mejia, Jon Heyman reports (Twitter links).

Duda will receive $6.725MM for the 2016 season. The slugger will land slightly above the $6.65MM mid-point in their recently-submitted arbitration numbers. He had filed at $7.4MM, with the team countering at $5.9MM. His final number lands just shy of MLBTR’s $6.8MM projection.

Now entering his age-30 campaign, Duda has emerged as a significant force at the plate. He owns a .249/.350/.483 slash with 57 home runs since the start of 2014. New York will be able to control him for one additional season through the arb process.

Mejia, meanwhile, settled at $2.47MM. Notably, as Heyman adds, he will take a rare pay cut from his prior year’s salary. New York tendered him a contract but sought a reduction on the price tag after Mejia missed most of the year due to successive PED suspensions. Of course, he still owes time on the second and will miss a sizable portion of the coming season — meaning he won’t earn the full amount agreed upon.

Jenrry Mejia Suspended 162 Games For Second Failed PED Test

By | at

Mets right-hander Jenrry Mejia has been suspended for 162 games following a second positive test for performance enhancing drugs, tweets Jon Heyman of CBS Sports. Mejia tested positive for both stanozolol and boldenone, tweets Joel Sherman of the New York Post.

The fairly stunning news comes just weeks after Mejia was activated from an 80-game PED suspension with which he was hit earlier this year. He has, in fact, pitched just 7 1/3 innings for the Mets this season. It’s natural to speculate that the Mets were made aware of the impending suspension prior to acquiring Tyler Clippard from the A’s, and thus, extra-motivated to strike a deal. However, GM Sandy Alderson tells reporters, including Adam Rubin of ESPN New York (Twitter link), that by the time he received a heads up on the Mejia suspension Monday evening, the trade for Clippard was finished.

Quick Hits: Payrolls, DH, Suspensions, Trade Candidates

By | at

ESPN’s Jayson Stark examines the rising payrolls around the game, noting that even 10 years ago, just three teams has payrolls topping $100MM. This year, Stark points out, 22 clubs have $100MM+ payrolls. Stark spoke with Tigers GM Dave Dombrowski, Giants CEO Larry Baer and sports economics expert Andy Zimbalist about the change and its impact around the league. Dombrowski notes that the extra Wild Card added to each league has made teams more willing to spend, because more teams believe they can win, and he also discussed the impact of increased payrolls on roster construction around the league. Baer commented that the additional sources of revenue — namely, TV deals, I would presume — have made it easier for teams to sign players to long-term deals, because revenue is easier to project. Not that long ago, Baer notes, revenue was tied much more heavily to ticket sales, and signing a young player to an extension was riskier, because teams could only project revenue a few years out at a time.

A few more miscellaneous notes from around the league…

  • Baseball America’s Matt Eddy provides a thorough, comprehensive explanation of his belief that it’s time for the National League to adopt the DH rule. Eddy notes that pitcher productivity is at an all-time low, relative to the production of non-pitchers — even as the production of non-pitchers declines in its own right. One NL assistant GM spoke to Eddy about the advantage that AL teams have not only in interleague games in AL stadiums, but in the ability to rest their best players while still giving them four at-bats. Eddy also argues that because improving their offensive prowess doesn’t accelerate their timeline to the Majors — no pitcher will be promoted because he’s a good hitter or withheld from the Majors to work on his swing — there is neither means nor incentive to improve their hitting skills. Eddy views the DH and the pitcher as “two sides of the same, hyper-specialized coin,” noting that a DH contributes solely to the offensive element of a game, whereas a pitcher functions as the key constituent of the defense. Interestingly, a 2013 poll of 18 MLB managers revealed that 12 of those managers were in favor of adding the DH to the NL, Eddy adds.
  • Adam Kilgore of the Washington Post looks at the recent suspensions of Mariners lefty David Rollins, Twins right-hander Ervin Santana, Mets closer Jenrry Mejia and Braves prospect Arodys Vizcaino for Stanozolol and investigates a possible connection. Commissioner Rob Manfred said earlier this week that the league conducts an investigation anytime that there are multiple suspensions for the same banned substance, though he has no reason to assume a connection at this point. Kilgore spoke with subject matter expert Dr. Charles Yesalis about the tests and was told, “There is no way, in my mind, this is one big coincidence.”
  • Cole Hamels, Johnny Cueto, Carlos Gonzalez, Scott Kazmir and Adrian Beltre top a list of midseason trade candidates compiled by Jim Bowden of ESPN (Insider subscription required/recommended). Kazmir’s inclusion is interesting, in that Bowden expects a trade to occur whether the A’s are contending or not, as he notes that the team won’t be able to afford to re-sign Kazmir. He speculates that Kazmir will be flipped, possibly for another Major League caliber starter to step into his spot, though as I pointed out in reviewing their offseason, the A’s already have a sizable reserve of rotation options from which to draw.
Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

hide arrows scroll to top